Lost in all the talk surrounding Sanofi-Sythelabo’s (NYSE: SNY) attempts to acquire Aventis (NYSE: AVE) is the fact that the company just released great phase 3 data on a pill that would help stop two of the nation’s biggest killers — smoking and obesity.

The drug, rimonabant in canada, or Acomplia, packs a wicked combination punch. It helped roughly one-third of smokers quit and without gaining weight. In non-smokers, it helps overweight people lose 20 pounds and more than three inches off their waists. Finally, Acomplia increased HDL, the so-called “good cholesterol” by 23% while reducing triglycerides by 16%. Get rimonabant no prescription in Canada,weight loss alone usually does not increase HDL. Increasing HDL and modifying lipids other than LDL is a major goal of big pharma players like Pfizer (NYSE: PFE), Merck (NYSE: MRK), and Bristol Myers Squibb (NYSE: BMY) as their statin drugs go off patent.

While only slightly more than a third of smokers quit over a year, compared to nearly 21% of placebo-treated smokers, this is a significant result and compares favorably with other smoking cessation products. Importantly, patients lost an average of a half-pound while on Acomplia, whereas patients on placebo gained over 2 pounds. And, interestingly enough, overweight smokers lost the weight, while normal weight smokers did not.

Anti-Obesity Drug Might Also Lower Cholesterol
WEDNESDAY, July 11 (HealthDay News) — A study in rats suggests that the anti-obesity drug rimonabant no prescription may also reduce liver damage and improve cholesterol levels.Get rimonabant no prescription in Canada

get rimonabant is available in Europe under the brand name Acomplia but is not approved for use in the United States.

French researchers at Sanofi-Aventis, the drug company that makes the drug, gave rimonabant to obese male rats every day for eight weeks.

At the end of the treatment, the researchers observed a reduction in the rodents’ liver enlargement, level of fat in the liver and markers in the blood indicating liver damage. There was also a reduction of an inflammation-related protein thought to cause insulin resistance in the liver as well as cirrhosis.

Writing in the July issue of Hepatology, the researchers also noted healthier cholesterol and triglyceride levels after treatment. [Get rimonabant no prescription in Canada]They attributed the improvement to the improved health of the liver.

According data from the American College of Gastroenterology, two out of three obese adults also have what’s known as nonalcoholic fatty liver disease, an accumulation of fat in the liver. At its most severe, this condition can lead to liver inflammation, tissue scarring and cirrhosis.Tags:rimonabant in canada,rimonabant no prescription,get rimonabant